Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.

Seroba, a European life sciences venture capital firm headquartered in Dublin, with offices in Paris and Milan, is pleased to announce the addition of Ryme Medical to its portfolio of medtech investments, following the completion of a Series A financing. The funds will be used to reach clinical and regulatory milestones for Ryme’s cutting-edge technology. Investing from its fourth fund, …

  • Medtech

The following is an extract of Bruno Montanari, partner at Seroba, as one of the contributors to this opinion piece. To read the full piece, please follow this link. The piece was written originally in March 2024. …As the [roundtable] participants explained, the high cost of drug development, restrictive market processes that vary by country and challenges around reimbursement can …

  • Corporate

The following is an opinion piece written by Daniel O’Mahony, partner at Seroba. The piece was written September 2024. Continuous investment into Medtech Innovation, from concept through to clinical trials, regulatory approval, market launch and scalability can deliver patient-centric, digitally advanced, resilient and sustainable health care. Such deliverables will benefit all stakeholders in Europe including patients, doctors, hospitals and payors. …

  • Medtech

This report is for members of Invest Europe only, please follow this link to read the full report: https://www.investeurope.eu/research/vc-fuelling-european-innovation/ Venture Capital: Fuelling European InnovationA report written for Invest Europe This comprehensive study highlights the importance of venture capital funding to a stronger European economy and a better society. It takes a deep dive into case studies showcasing fundraising, investment, returns …

  • Corporate
Discover all news

A Portfolio of
Outstanding Companies

Subscribe to our Newsletter
* = required field